 IRVINE, CA ACCESSWIRE February 26, 2020 Hancock Jaffe Laboratories, Inc. Nasdaq:HJLI, HJLIW, a developer of medical devices that restore cardiac and vascular health, announced today that on Wednesday, March 4, 2020, Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLIs first-in-man VenoValve study in Colombia, will present updated VenoValve data at the Thirty Second Annual Meeting of the American Venous Forum. The meeting is taking place March 3 to March 6 at the Omni Amelia Island Plantation Hotel at Amelia Island, Florida. Contemporaneously with Dr. Ulloas presentation at the American Venous Forum meeting, HJLI will release select VenoValve data from the presentation, which will include updated reports from 8 patients that are 180 days post VenoValve surgery including 1 Patient that is now 365 days post VenoValve surgery. 